Leprosy, a disease caused by Mycobacterium leprae, has polymorphic neurocutaneous
manifestations strongly correlated with the host immune response. Peripheral neural …

Context The most reported viral co‐infections in leprosy are human immunodeficiency virus
(HIV), human T‐cell lymphotropic virus (HTLV), hepatitis B virus (HBV), hepatitis C virus …

Background Leprosy is associated with different dermatologic and neurologic manifestations
within a wide clinical spectrum, causing a great diagnostic challenge. Therefore, we aimed …

Adjuvants play a critical role in enhancing vaccine efficacy; however, there is a need to
develop new immunomodulatory compounds to address emerging pathogens and to …

Leprosy is a chronic neurodermatological disease caused by the bacillus Mycobacterium
leprae. Recent studies show that SNPs in genes related to miRNAs have been associated …

Purpose Psoriasis (Ps) and leprosy are chronic inflammatory skin disorders, characterised
by enhanced innate and adaptive immunity. Ps and leprosy rarely coexist. The molecular …

Background Leprosy is caused by Mycobacterium leprae and Mycobacterium lepromatosis.
Most of the affected population lives in low-income countries and may take up to 10 years to …

Introduction Leprosy is a chronic infectious condition and the main cause of neuropathy that
occurs brought on by M. leprae. It is known that the biological characteristics of the human …

This study investigates the efficacy of proteomic analysis of human remains to identify active
infections in the past through the detection of pathogens and the host response to infection …

The treatment of multibacillary cases of leprosy with multidrug therapy (MDT) comprises 12
doses of a combination of rifampicin, dapsone and clofazimine. Previous studies have …